Nationwide data show that although only about 12 percent of X-ray exams are for interventional cardiology or ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
Feature | Dave Fornell
(Editor's note - this article had links to newer content added April 2017)
There have been several advances in ...
August 06, 2013
June 28, 2013 — Maquet Cardiovascular LLC announced it has acquired LAAx Inc., a privately held company that has ...
June 28, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
May 16, 2013 — New research presented at Heart Rhythm 2013 continues to show promising results for focal impulse and ...
May 16, 2013
May 13, 2013 – New study data released at the Heart Rhythm Society (HRS) meeting last week validates the importance of ...
May 15, 2013
May 14, 2013 — nContact Inc. said it received conditional approval for an investigational device exemption (IDE) from ...
May 14, 2013Sponsored Content
Blog
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
November 13, 2023
May 14, 2013 — Biosense Webster Inc. announced the 12-month safety and effectiveness results of the Thermocool ...
May 14, 2013
May 13, 2013 — Boston Scientific reports that the four-year follow-up data from the PROTECT AF clinical trial demonstrat ...
May 13, 2013
First Patient Enrolled in Study Evaluating the Multi-Electrode nMARQ Pulmonary Vein Isolation System
May 13, 2013 — Biosense Webster Inc. announced the first patient has been enrolled in the reMARQable clinical study ...
May 13, 2013Sponsored Content
Blog
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
November 02, 2023
April 30, 2013 — The U.S. Food and Drug Administration (FDA) approved Kcentra (prothrombin complex concentrate, human) ...
April 30, 2013
April 5, 2013 — A study led by researchers at the University of North Carolina indicates a newly approved blood thinner ...
April 05, 2013
April 4, 2013 — Endosense has announced that the results of its EFFICAS I prospective multi-center study have led to the ...
April 04, 2013Sponsored Content
Blog | ECG
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
August 24, 2022
April 4, 2013 — iRhythm Technologies Inc. announced clinical study findings showing that use of the Zio Patch resulted ...
April 04, 2013
March 19, 2013 — Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co ...
March 19, 2013
March 13, 2013 — St. Jude Medical Inc. announced the first patient implant in a new pivotal trial evaluating the company ...
March 13, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now